CYTOKINETICS INC — Director's Dealing 2021

Jan 15, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2021-01-14

Reporting Person: Malik Fady Ibraham (EVP Research & Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-14	Common Stock	M	617	$9.42	Acquired	151058	Direct
2021-01-14	Common Stock	S	617	$19.2495	Disposed	150441	Direct
2021-01-14	Common Stock	M	11883	$9.42	Acquired	162324	Direct
2021-01-14	Common Stock	S	11883	$19.2495	Disposed	150441	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-14	Incentive Stock Option (right to buy)	$9.42	M	11883	Disposed	2021-02-28	Common Stock (11883)	Direct
2021-01-14	Non-Qualified Stock Option (right to buy)	$9.42	M	617	Disposed	2021-02-28	Common Stock (617)	Direct

Footnotes

F1: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 31, 2020.

F2: Includes 1,470 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP).